Brief: SynAct Pharma Q4 Pre-Tax Loss Narrows To SEK 7.3 Million
Feb 13 (Reuters) - SYNACT PHARMA AB SYNACT.TE :
* Q4 PRE-TAX LOSS SEK 7.3 MILLION VERSUS LOSS SEK 9.3
MILLION YEAR
AGO
Source text: http://bit.ly/2GbjrPJ
Further company coverage: SYNACT.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on SynAct Pharma AB
See all newsBrief: SynAct: Shareholding Board, Management Sign Lock-Up Agreements
Sweden's SynAct Pharma posts wider Q1 net loss as expenses rise
Brief: SynAct Pharma Q1 Sales SEK 0
Brief: SynAct Pharma Carries Out Directed Issue Of New Shares
Brief: Synact Pharma Appoints Ann Kristin Led As CFO Effective March 2026